Award
National Cancer Institute 5R33CA278564-03
Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis
Recipient
Not specified
Award Amount
$404,788.00
Ceiling
$404,788.00
Awarded
February 09, 2026
Identifier
5R33CA278564-03
Research grant awarded by the National Cancer Institute to develop CRISPR-based genome-wide screening techniques in personalized tumor models.
Description
A research grant opportunity focused on developing advanced CRISPR-based screening techniques in tumor models, with a focus on in vivo applications and multiplex genetic screens.